Herve Fages - 16 Mar 2022 Form 4 Insider Report for Evoqua Water Technologies Corp.

Role: Executive Vice President
Signature: /s/ John DiMascio, Attorney-in-Fact for Herve Fages
Issuer symbol: N/A
Transactions as of: 16 Mar 2022
Net transactions value: -$919,765
Form type: 4
Filing time: 17 Mar 2022, 16:35:05 UTC
Previous filing: 10 Mar 2022
Next filing: 20 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AQUA	Common Stock	Options Exercise	$168,102	+12,085	+29%	$13.91	53,400	16 Mar 2022	Direct	F1, F2
transaction	AQUA	Common Stock	Options Exercise	$206,820	+8,353	+16%	$24.76	61,753	16 Mar 2022	Direct	F1, F2
transaction	AQUA	Common Stock	Sale	$919,765	-20,438	-33%	$45.00	41,315	16 Mar 2022	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AQUA	Stock Option (Right to Buy)	Options Exercise	$168,102	-12,085	-45%	$13.91	14,938	16 Mar 2022	Common Stock	12,085	$13.91	Direct	F1, F4
transaction	AQUA	Stock Option (Right to Buy)	Options Exercise	$206,820	-8,353	-25%	$24.76	25,062	16 Mar 2022	Common Stock	8,353	$24.76	Direct	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2022.
F2	The amount of these securities includes 34,076 unvested restricted stock units in respect of the issuer's common stock.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.0000 to $45.0300, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	This option vests in four equal installments, three of which occurred on each of March 1, 2020, March 1, 2021, and March 1, 2022, and one of which will occur on March 1, 2023, subject to the reporting person's continued employment with the issuer through such date.
F5	This option vests in four equal installments, one of which occurred on February 16, 2022, and three of which will occur on each of January 1, 2023, January 1, 2024, and January 1, 2025, subject to the reporting person's continued employment with the issuer through each such date.